Entera Historical Balance Sheet

ENTX Stock

USD 2.38 0.01 0.42%

Trend analysis of Entera Bio balance sheet accounts such as Other Current Liabilities of 1.3 M or Total Current Liabilities of 1 M provides information on Entera Bio's total assets, liabilities, and equity, which is the actual value of Entera Bio to its prevalent stockholders. By breaking down trends over time using Entera Bio balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Entera Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Entera Bio is a good buy for the upcoming year.

Entera Bio Inventory

(251,370)

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Entera Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide.

About Entera Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Entera Bio at a specified time, usually calculated after every quarter, six months, or one year. Entera Bio Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Entera Bio and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Entera currently owns. An asset can also be divided into two categories, current and non-current.

Entera Bio Balance Sheet Chart

Entera Bio Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Entera Bio uses and utilizes its capital. It also shows what exactly a company owns and owes.

At this time, Entera Bio's Non Current Liabilities Other is fairly stable compared to the past year. Net Working Capital is likely to rise to about 12.9 M in 2024, whereas Short and Long Term Debt Total is likely to drop slightly above 370.5 K in 2024.

Total Assets Short Long Term Debt Total Total Current Liabilities Other Liab Retained Earnings Non Current Liabilities Total

Add Fundamental

Total Assets

Total assets refers to the total amount of Entera Bio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Entera Bio books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Entera Bio balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Entera Bio are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Most accounts from Entera Bio's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Entera Bio current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Entera Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide.At this time, Entera Bio's Non Current Liabilities Other is fairly stable compared to the past year. Net Working Capital is likely to rise to about 12.9 M in 2024, whereas Short and Long Term Debt Total is likely to drop slightly above 370.5 K in 2024.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	302K	91K	390K	370.5K
Total Assets	26.0M	13.1M	11.8M	13.9M

Short Long Term Debt Total Total Assets

Entera Bio balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Long Term Debt	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Property Plant Equipment
Total Assets		-0.75	0.68	0.2	0.82	0.82	0.81	0.61	-0.96	-0.72	0.05	0.99	-0.24	-0.82	1.0	0.54	-0.67	0.28	0.77	-0.64	0.59	0.72	1.0	-0.6	-0.52	0.61
Short Long Term Debt Total	-0.75		-0.38	0.31	-0.86	-0.45	-0.86	-0.51	0.9	0.82	-0.35	-0.73	0.25	0.65	-0.77	-0.56	0.75	-0.17	-0.83	0.8	-0.68	-0.91	-0.75	0.63	0.66	-0.63
Other Current Liab	0.68	-0.38		0.24	0.43	0.6	0.42	0.75	-0.6	-0.23	-0.41	0.68	0.16	-0.4	0.67	0.02	-0.3	-0.09	0.29	-0.27	0.39	0.36	0.68	-0.26	-0.24	0.44
Total Current Liabilities	0.2	0.31	0.24		0.05	0.35	0.03	0.11	0.01	0.06	-0.09	0.19	0.24	-0.44	0.18	-0.09	-0.14	-0.18	-0.01	0.03	0.14	-0.22	0.2	-0.24	0.08	0.23
Total Stockholder Equity	0.82	-0.86	0.43	0.05		0.54	1.0	0.6	-0.88	-0.88	0.2	0.8	-0.31	-0.74	0.83	0.66	-0.96	0.25	0.93	-0.96	0.74	0.72	0.82	-0.92	-0.72	0.69
Other Liab	0.82	-0.45	0.6	0.35	0.54		0.52	0.41	-0.71	-0.32	0.12	0.8	0.18	-0.58	0.81	0.25	-0.4	0.0	0.46	-0.34	0.5	0.51	0.81	-0.36	-0.12	0.63
Net Tangible Assets	0.81	-0.86	0.42	0.03	1.0	0.52		0.62	-0.88	-0.9	0.18	0.79	-0.34	-0.74	0.82	0.68	-0.96	0.27	0.94	-0.97	0.75	0.72	0.82	-0.92	-0.75	0.67
Property Plant And Equipment Net	0.61	-0.51	0.75	0.11	0.6	0.41	0.62		-0.62	-0.56	-0.41	0.64	-0.09	-0.47	0.62	0.42	-0.54	0.13	0.6	-0.53	0.7	0.52	0.61	-0.5	-0.62	0.48
Net Debt	-0.96	0.9	-0.6	0.01	-0.88	-0.71	-0.88	-0.62		0.83	-0.19	-0.96	0.29	0.78	-0.96	-0.64	0.73	-0.31	-0.86	0.74	-0.69	-0.85	-0.96	0.64	0.63	-0.66
Retained Earnings	-0.72	0.82	-0.23	0.06	-0.88	-0.32	-0.9	-0.56	0.83		-0.21	-0.74	0.56	0.75	-0.74	-0.86	0.83	-0.5	-0.94	0.85	-0.72	-0.71	-0.73	0.77	0.9	-0.55
Accounts Payable	0.05	-0.35	-0.41	-0.09	0.2	0.12	0.18	-0.41	-0.19	-0.21		0.06	0.12	-0.21	0.05	0.21	-0.22	-0.09	0.25	-0.24	0.27	0.38	0.05	-0.17	0.04	0.43
Cash	0.99	-0.73	0.68	0.19	0.8	0.8	0.79	0.64	-0.96	-0.74	0.06		-0.29	-0.78	0.99	0.63	-0.64	0.38	0.79	-0.61	0.62	0.71	0.99	-0.57	-0.56	0.62
Non Current Assets Total	-0.24	0.25	0.16	0.24	-0.31	0.18	-0.34	-0.09	0.29	0.56	0.12	-0.29		0.21	-0.27	-0.73	0.27	-0.92	-0.51	0.31	0.11	-0.2	-0.27	0.25	0.43	0.33
Long Term Debt	-0.82	0.65	-0.4	-0.44	-0.74	-0.58	-0.74	-0.47	0.78	0.75	-0.21	-0.78	0.21		-0.81	-0.49	0.68	-0.14	-0.72	0.61	-0.62	-0.66	-0.82	0.65	0.58	-0.56
Cash And Short Term Investments	1.0	-0.77	0.67	0.18	0.83	0.81	0.82	0.62	-0.96	-0.74	0.05	0.99	-0.27	-0.81		0.57	-0.67	0.32	0.79	-0.65	0.59	0.74	1.0	-0.61	-0.54	0.6
Common Stock Shares Outstanding	0.54	-0.56	0.02	-0.09	0.66	0.25	0.68	0.42	-0.64	-0.86	0.21	0.63	-0.73	-0.49	0.57		-0.61	0.81	0.86	-0.63	0.54	0.54	0.56	-0.57	-0.69	0.33
Non Current Liabilities Total	-0.67	0.75	-0.3	-0.14	-0.96	-0.4	-0.96	-0.54	0.73	0.83	-0.22	-0.64	0.27	0.68	-0.67	-0.61		-0.18	-0.89	0.99	-0.74	-0.58	-0.67	0.99	0.71	-0.67
Other Current Assets	0.28	-0.17	-0.09	-0.18	0.25	0.0	0.27	0.13	-0.31	-0.5	-0.09	0.38	-0.92	-0.14	0.32	0.81	-0.18		0.49	-0.21	-0.03	0.17	0.31	-0.16	-0.37	-0.21
Other Stockholder Equity	0.77	-0.83	0.29	-0.01	0.93	0.46	0.94	0.6	-0.86	-0.94	0.25	0.79	-0.51	-0.72	0.79	0.86	-0.89	0.49		-0.9	0.74	0.78	0.78	-0.83	-0.74	0.58
Total Liab	-0.64	0.8	-0.27	0.03	-0.96	-0.34	-0.97	-0.53	0.74	0.85	-0.24	-0.61	0.31	0.61	-0.65	-0.63	0.99	-0.21	-0.9		-0.72	-0.63	-0.64	0.95	0.73	-0.64
Property Plant And Equipment Gross	0.59	-0.68	0.39	0.14	0.74	0.5	0.75	0.7	-0.69	-0.72	0.27	0.62	0.11	-0.62	0.59	0.54	-0.74	-0.03	0.74	-0.72		0.65	0.58	-0.69	-0.7	0.89
Short Long Term Debt	0.72	-0.91	0.36	-0.22	0.72	0.51	0.72	0.52	-0.85	-0.71	0.38	0.71	-0.2	-0.66	0.74	0.54	-0.58	0.17	0.78	-0.63	0.65		0.72	-0.47	-0.45	0.53
Total Current Assets	1.0	-0.75	0.68	0.2	0.82	0.81	0.82	0.61	-0.96	-0.73	0.05	0.99	-0.27	-0.82	1.0	0.56	-0.67	0.31	0.78	-0.64	0.58	0.72		-0.61	-0.53	0.59
Short Term Debt	-0.6	0.63	-0.26	-0.24	-0.92	-0.36	-0.92	-0.5	0.64	0.77	-0.17	-0.57	0.25	0.65	-0.61	-0.57	0.99	-0.16	-0.83	0.95	-0.69	-0.47	-0.61		0.67	-0.63
Intangible Assets	-0.52	0.66	-0.24	0.08	-0.72	-0.12	-0.75	-0.62	0.63	0.9	0.04	-0.56	0.43	0.58	-0.54	-0.69	0.71	-0.37	-0.74	0.73	-0.7	-0.45	-0.53	0.67		-0.51
Property Plant Equipment	0.61	-0.63	0.44	0.23	0.69	0.63	0.67	0.48	-0.66	-0.55	0.43	0.62	0.33	-0.56	0.6	0.33	-0.67	-0.21	0.58	-0.64	0.89	0.53	0.59	-0.63	-0.51

Click cells to compare fundamentals

Entera Bio Account Relationship Matchups

Entera Bio balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	16.7M	10.3M	26.0M	13.1M	11.8M	13.9M
Other Current Liab	3.8M	(189K)	2.8M	(134K)	874K	1.3M
Total Current Liabilities	4.6M	3.3M	3.2M	1.3M	1.1M	1.0M
Total Stockholder Equity	11.9M	6.7M	22.6M	11.8M	10.4M	10.9M
Net Tangible Assets	11.3M	6.1M	22.6M	11.8M	13.5M	14.2M
Property Plant And Equipment Net	462K	192K	395K	139K	488K	305.4K
Net Debt	(14.9M)	(8.2M)	(24.6M)	(12.2M)	(10.6M)	(11.2M)
Retained Earnings	(62.9M)	(72.9M)	(82.4M)	(95.5M)	(104.4M)	(99.2M)
Accounts Payable	334K	1.8M	166K	1.3M	83K	78.9K
Cash	15.2M	8.6M	24.9M	12.3M	11.0M	11.8M
Non Current Assets Total	1.1M	1.2M	658K	278K	508K	631.1K
Cash And Short Term Investments	15.2M	8.6M	24.9M	12.3M	11.0M	12.3M
Common Stock Shares Outstanding	12.1M	18.4M	26.1M	28.8M	29.0M	19.3M
Liabilities And Stockholders Equity	16.7M	10.3M	26.0M	13.1M	11.8M	13.9M
Non Current Liabilities Total	192K	324K	261K	32K	288K	273.6K
Other Current Assets	97K	93K	254K	294K	238K	188.5K
Other Stockholder Equity	63.4M	70.6M	105.0M	107.2M	114.7M	63.3M
Total Liab	4.8M	3.6M	3.4M	1.4M	1.4M	1.3M
Property Plant And Equipment Gross	462K	548K	395K	229K	488K	359.9K
Total Current Assets	15.6M	9.1M	25.3M	12.8M	11.3M	13.0M
Accumulated Other Comprehensive Income	13.1M	11.4M	9.0M	41K	36.9K	35.1K
Property Plant Equipment	462K	548K	395K	229K	263.4K	337.8K
Non Currrent Assets Other	(1.1M)	356K	46K	96K	6K	5.7K
Net Invested Capital	11.9M	6.7M	22.6M	11.8M	10.4M	7.2M
Net Working Capital	11.0M	5.8M	22.2M	11.5M	10.2M	12.9M
Current Deferred Revenue	267K	1.4M	15K	43K	38.7K	36.8K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

WD	Walker Dunlop
MSFT	Microsoft
BAC	Bank of America

When determining whether Entera Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Entera Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Entera Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Entera Bio Stock:

How To Invest In Entera

Details

Is Entera Stock a good investment?

Details

What is Entera Bio's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide.

You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for Entera Stock analysis

When running Entera Bio's price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.

	Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Insider Screener Find insiders across different sectors to evaluate their impact on performance

Is Entera Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Entera Bio. If investors know Entera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Entera Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.28)

Quarterly Revenue Growth

(0.92)

Return On Assets

(0.50)

Return On Equity

(0.92)

The market value of Entera Bio is measured differently than its book value, which is the value of Entera that is recorded on the company's balance sheet. Investors also form their own opinion of Entera Bio's value that differs from its market value or its book value, called intrinsic value, which is Entera Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Entera Bio's market value can be influenced by many factors that don't directly affect Entera Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Entera Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Entera Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Entera Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Entera Historical Balance Sheet

Entera Bio Inventory

(251,370)

About Entera Balance Sheet Analysis

Entera Bio Balance Sheet Chart

Total Assets

Total Current Liabilities

Retained Earnings

Entera Bio balance sheet Correlations

Entera Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Entera Bio balance sheet Accounts

Also Currently Popular

Complementary Tools for Entera Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Tangible Assets	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Cash And Short Term Investments
Cash	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Cash

Total Liab	- 0.97	Net Tangible Assets
Total Current Assets	- 0.96	Net Debt
Cash And Short Term Investments	- 0.96	Net Debt
Cash	- 0.96	Net Debt
Non Current Liabilities Total	- 0.96	Net Tangible Assets
Total Liab	- 0.96	Total Stockholder Equity